A once-a-day pill could transform the lives of migraine sufferers after it was given the green light for NHS use. The National Institute for Health and Care Excellence (NICE) has recommended a ...

Final draft guidance says that CGRP antagonist Aquipta (atogepant) can be used for migraine prevention in ... as Scotland gave a green light to the drug in this indication last October, and ...

Pfizer's $1.2 billion licensing deal with Biohaven for rights to oral migraine drug rimegepant is approaching a payoff after the European Commission approved the drug.